BEMA Fentanyl

DRUG2 trials

Sponsors

BioDelivery Sciences International

Conditions

CancerPainRespiratory Depression

Phase 3

Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy

CompletedNCT00293020

BioDelivery Sciences InternationalCancer, Pain

Start: 2006-02-28End: 2008-06-30Updated: 2012-10-05

Long-term Extension Study of BEMA™ Fentanyl

CompletedNCT00696137

BioDelivery Sciences InternationalRespiratory Depression

Start: 2008-06-30End: 2009-07-31Updated: 2019-09-24